Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide



Veerapen et al.


Page 6


Sponsored Document            Sponsored Document            Sponsored Document


4. Hong S. Scherer D.C. Mendiratta S.K. Serizawa I. Koezuka Y. Van K.L. Immunol. Rev. 1997;169:31.
[PubMed: 10450506]

5. Kawano T. Cui J. Koezuka Y. Toura I. Kaneko Y. Motoki K. Ueno H. Nakagawa R. Sato H. Kondo
E. Koseki H. Taniguchi M. Science 1997;278:1626. [PubMed: 9374463]

6. Crowe N. Uldrich A.P. Kyparissoudis K. Hammond K.J.L. Hayakawa Y. Sidobre S. Keating R.
Kronenberg M. Smyth M.J. Godfrey D.I. J. Immunol. 2003;171:4020. [PubMed: 14530322]

7. Burdin N. Brossay L. Kronenberg M. Eur. J. Immunol. 1999;29:2014. [PubMed: 10382765]

8. Carnaud C. Lee D. Donnars O. Park S.H. Beavis A. Koezuka Y. Bendelac A. J. Immunol.

1999;163:4647. [PubMed: 10528160]

9. Taniguchi M. Harada M. Kojo S. Nakayama T. Wakao H. Annu. Rev. Immnunol. 2003;21:483.

10. Godfrey D.I. MacDonald H.R. Kronenberg M. Smyth M.J. Van K.L. Nat. Rev. Immunol. 2004;4:231.
[PubMed: 15039760]

11. Gonzalez-Aseguinolaza G. Van Kaer L. Bergmann C.C. Wilson J.M. Schmieg J. Kronenberg M.
Nakayama T. Taniguchi M. Koezuka Y. Tsuji M. J. Exp. Med. 2002;195:617. [PubMed: 11877484]

12. Miyamoto K. Miyake S. Yamamura T. Nature 2001;413:513.

13. Chiba A. Oki S. Miyamoto K. Hashimoto H. Yamamura T. Miyake S. Arthritis Rheum. 2004;50:305.
[PubMed: 14730629]

14. (a) Takikawa H. Muto S.E. Mori K. Tetrahedron 1998;54:3141. (b) Figueroa-Perez S. Schmidt R.R.
Carbohydr. Res. 2000;328:95. [PubMed: 11028777] (c) Xia C. Yao Q. Schuemann J. Rossy E. Chen
W. Zhu L. Zhang W. De Libero G. Wang P.G. Bioorg. Med. Chem. Lett. 2006;16:2195. [PubMed:
16458002] (d) Fan G.T. Pan Y.S. Lu K.C. Cheng Y.P. Lin W.C. Lin S. Lin C.H. Wong C.H. Fang
J.M. Lin C.C. Tetrahedron 2005;61:1855. (e) Ndonye R.M. Izmirian D.P. Dunn M.F. Yu K.O.A.
Porcelli S.A. Khurana A. Kronenberg M. Richardson S.K. Howell A.R. J. Org. Chem.

2005;70:10260. [PubMed: 16323834] (f) Michieletti M. Bracci A. Compostella F. De Libero G. Mori
L. Fallarini S. Lombardi G. Panza L. J. Org. Chem. 2008;73:9192. [PubMed: 18956839] (g) Lee A.
Farrand K.J. Dickgreber N. Hayman C.M. Juers S. Hermans I.F. Painter G.F. Carbohydr. Res.

2006;341:2785. [PubMed: 17014832]

15. Kimura A. Imamura A. Ando H. Ishida H. Kiso M. Synlett 2006;15:2379.

16. Akimoto K. Natori T. Morita M. Tetrahedron Lett. 1993;34:5593.

17. Van den Berg R.J.B.H.N. Boltje T.J. Verhagen C.P. Litjens R.E.J.N. Van der Marel G.A. Overkleeft
H.S. J. Org. Chem. 2006;71:836. [PubMed: 16409007]

18. Imamura A. Ando H. Korogi S. Tanabe G. Muraoka O. Ishida H. Kiso M. Tetrahedron Lett.
2003;44:6725.

19. Hada N. Oka J. Nishiyama A. Takeda T. Tetrahedron Lett. 2006;47:6647.

20. (a) Stork G. Kim G. J. Am. Chem. Soc. 1992;114:1087. (b) Bols M. J. Chem. Soc., Chem. Commun.
1992;12:913. (c) Bols M. J. Chem. Soc., Chem. Commun. 1993;9:791. (d) Bols M. Acta Chem.
Scand. 1993;47:829.

21. Bols M. Tetrahedron 1993;49:10049.

22. Saito S. Ichinose K. Sasaki Y. Sumita S. Chem. Pharm. Bull. 1992;40:3261. [PubMed: 1294329]

23. Prigozy T.I. Naidenko O. Qasba P. Elewaut D. Brossay L. Khurana A. Natori T. Koezuka Y. Kulkarni
A. Kronenberg M. Science 2001;291:664. [PubMed: 11158680]

24. Kinjo Y. Pei B. Bufali S. Raju R. Richardson Stewart K. Imamura M. Fujio M. Wu D. Khurana A.
Kawahara K. Wong C.H. Howell A.R. Seeberger P.H. Kronenberg M. Chem. Biol. 2008;15:654.
[PubMed: 18635002]and references therein

25. (a) Brigl M. Bry L. Kent S.C. Gumperz J.E. Brenner M.B. Nat. Immunol. 2003;4:1230. [PubMed:
14578883] (b) Gumperz J.E. Roy C. Makowska A. Lum D. Sugita M. Podrebarac T. Koezuka Y.
Porcelli S.A. Cardell S. Brenner M.B. Behar S.M. Immunity 2000;12:211. [PubMed: 10714687] (c)
Sugita M. van Der Wel N. Rogers R.A. Peters P.J. Brenner M.B. Proc. Natl. Acad. Sci. U.S.A.
2000;97:8445. [PubMed: 10890914]

26. Selected data for new compounds6: 1H NMR (CDCl3): δ 7.92-8.04 (10H, m, Ar-H), 7.27-7.64 (10H,
m, Ar-
H), 5.80 (1H, dd, H-2, J2,1 = 3.6), 5.55 (1H, dd, J3,2 = 10.6, J3,4 = 2.8 Hz, H-3), 5.42-5.50
(2H, m, H-3
Cer, H-4Cer), 5.31 (1H, d, H-1), 4.87 (d, 1H, H-4), 4.13-4.27 (m, 3H, H-2Cer, H-6a,,
H-6b), 4.00-4.13 (m, 1H, H-5), 3.85-3.90 (m, 1H, H-1a
Cer), 3.68 (dd, 1H, J1a,1b = 10.4, J1b,

Published as: Bioorg Med Chem Lett. 2009 August 01; 19(15): 4288-4291.



More intriguing information

1. Bidding for Envy-Freeness: A Procedural Approach to n-Player Fair Division Problems
2. The name is absent
3. WP 36 - Women's Preferences or Delineated Policies? The development or part-time work in the Netherlands, Germany and the United Kingdom
4. The name is absent
5. Industrial Cores and Peripheries in Brazil
6. The name is absent
7. TECHNOLOGY AND REGIONAL DEVELOPMENT: THE CASE OF PATENTS AND FIRM LOCATION IN THE SPANISH MEDICAL INSTRUMENTS INDUSTRY.
8. The Nobel Memorial Prize for Robert F. Engle
9. The name is absent
10. Education and Development: The Issues and the Evidence